Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, Ishikawa Y, Togashi T, Ueda K.

Clin Vaccine Immunol. 2014 Feb;21(2):188-95. doi: 10.1128/CVI.00377-13. Epub 2013 Dec 11.

3.

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.

Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P.

Hum Vaccin Immunother. 2015;11(6):1418-25. doi: 10.1080/21645515.2015.1011996. Review.

4.

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).

Kikukawa A, Gomi Y, Akechi M, Onishi T, Manabe S, Namazue J, Fuke I, Ishikawa T, Okuno Y, Ueda S.

Vaccine. 2012 Mar 16;30(13):2329-35. doi: 10.1016/j.vaccine.2012.01.054. Epub 2012 Jan 31.

PMID:
22306856
5.

Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK(®)V) in children.

Okada K, Iwasa T, Namazue J, Akechi M, Ueda S; JE Vaccine Clinical Study Group.

Vaccine. 2012 Sep 7;30(41):5967-72. doi: 10.1016/j.vaccine.2012.07.034. Epub 2012 Jul 25.

PMID:
22841478
6.

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.

Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, Schranz S, Jong E, Klingler A, Dewasthaly S, Klade CS.

Lancet. 2007 Dec 1;370(9602):1847-53.

PMID:
18061060
7.

Product review on the JE vaccine IXIARO.

Firbas C, Jilma B.

Hum Vaccin Immunother. 2015;11(2):411-20. doi: 10.4161/21645515.2014.983412. Review.

8.

An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses.

Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N.

J Gen Virol. 2010 Jun;91(Pt 6):1407-17. doi: 10.1099/vir.0.019190-0. Epub 2010 Feb 3.

9.

Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: a case-control study.

Muangchana C, Henprasertthae N, Nurach K, Theppang K, Yoocharoen P, Varinsathien P, Techathawat S, Sanohsieng S, Anantapreecha S.

Vaccine. 2012 Jan 5;30(2):361-7. doi: 10.1016/j.vaccine.2011.10.083. Epub 2011 Nov 7.

PMID:
22075090
10.

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Mar 12;59(RR-1):1-27.

11.

Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.

Fan YC, Chen JM, Chiu HC, Chen YY, Lin JW, Shih CC, Chen CM, Chang CC, Chang GJ, Chiou SS.

PLoS Negl Trop Dis. 2012;6(9):e1834. doi: 10.1371/journal.pntd.0001834. Epub 2012 Sep 27.

12.

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine.

Kuzuhara S, Nakamura H, Hayashida K, Obata J, Abe M, Sonoda K, Nishiyama K, Sugawara K, Takeda K, Honda T, Matsui H, Shigaki T, Kino Y, Mizokami H, Tanaka M, Mizuno K, Ueda K.

Vaccine. 2003 Nov 7;21(31):4519-26.

PMID:
14575762
14.

IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.

Jelinek T.

Expert Rev Vaccines. 2013 Aug;12(8):859-69. doi: 10.1586/14760584.2013.835638. Review.

PMID:
23984958
15.

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, Lindquist L, Pakkanen SH, Huhtamo E, Vapalahti O, Kantele A.

Clin Infect Dis. 2012 Sep;55(6):825-34. doi: 10.1093/cid/cis542. Epub 2012 Jun 13.

16.

[Study on safety and effect of purified inactivited Japanese encephalitis vaccine (primary hamster kidney cell, PHK)].

Li W, Jia LL, Zou Y.

Zhongguo Yi Miao He Mian Yi. 2009 Aug;15(4):333-6. Chinese.

PMID:
20077733
17.

Update on Japanese encephalitis vaccine for children: United States, May 2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 May 27;60(20):664-5.

18.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
19.

Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.

Woolpert T, Staples JE, Faix DJ, Nett RJ, Kosoy OI, Biggerstaff BJ, Johnson BW, Sracic M, Fischer M.

Vaccine. 2012 Apr 26;30(20):3090-6. doi: 10.1016/j.vaccine.2012.02.063. Epub 2012 Mar 6.

PMID:
22406277
20.

IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.

Appaiahgari MB, Vrati S.

Expert Rev Vaccines. 2010 Dec;9(12):1371-84. doi: 10.1586/erv.10.139. Review.

PMID:
21105774
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk